Abeona Therapeutics.jpg
Abeona Therapeutics Cleared to Initiate Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
December 09, 2019 08:45 ET | Abeona Therapeutics Inc.
FDA removes clinical hold; Company may proceed with VIITAL™ study Company expects to initiate study in the first quarter of 2020 Primary endpoint confirmed as proportion of wounds with greater than...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of SRC Energy, Pivotal Software, MAM Software Group, and Fibrocell Science on behalf of Stockholders and Encourages Investors to Contact the Firm
October 15, 2019 10:56 ET | Bragar Eagel & Squire
NEW YORK, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of SRC Energy Inc. (NYSE:...
Atos permet une adoption plus rapide du cloud avec les nouveaux accélérateurs Syntbots pour la Plateforme Pivotal
October 09, 2019 08:00 ET | Atos International
         Atos permet une adoption plus rapide du cloud avec les nouveaux accélérateurs SyntBots pour la Plateforme Pivotal Paris, France - le 9 octobre 2019 – Atos, leader international de la...
Atos Delivers Faster Cloud Adoption with New Syntbots Accelerators for Pivotal Platform
October 09, 2019 08:00 ET | Atos International
         Atos Delivers Faster Cloud Adoption with New SyntBots Accelerators for Pivotal Platform Paris, France - October 9, 2019 – Atos, a global leader in digital transformation, today announced...
Atos wins Breakthrough System Integrator Partner of the Year Award from Pivotal
October 08, 2019 08:00 ET | Atos International
Paris, France, October 8 2019 – Atos, global leader in digital transformation, today announces that it has been named a Breakthrough System Integrator Partner of the Year for EMEA by Pivotal Software,...
Atos remporte le prix du Partenaire intégrateur de systèmes innovant de l’année décerné par Pivotal
October 08, 2019 08:00 ET | Atos International
Paris, le 8 octobre 2019 – Atos, leader international de la transformation digitale, annonce aujourd’hui avoir été nommé le partenaire intégrateur de systèmes innovant de l’année pour la zone EMEA...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B
September 03, 2019 07:00 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Sept. 03, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Schall Firm Logo 2.jpg
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Pivotal Software, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
June 18, 2019 12:20 ET | Schall Law
LOS ANGELES, June 18, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pivotal...
Schall Firm Logo 2.jpg
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pivotal Software, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
June 10, 2019 14:23 ET | Schall Law
LOS ANGELES, June 10, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pivotal...
Retrophin Logo.jpg
Retrophin Reports Third Quarter 2018 Financial Results
November 01, 2018 16:01 ET | Retrophin, Inc.
Pivotal programs enrolling towards first data readout in 2019 Phase 2 study of CNSA-001 in PKU underway; top-line results expected in first half 2019 Completed offering of $276 million...